Brazilian IP News - MJZanon - Page 150

University of California awarded new U.S. CRISPR-Cas9 patent

Tuesday, August 20, 2019 Impotence is being noted to be the maximum selling ED medication worldwide. purchase viagra online Although

Canntab Therapeutics Limited receives initial indication of patentability for immediate release cannabidiol formulation

Canntab Therapeutics Limited, the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic application, is pleased

Brazilian Supreme Court takes position on supply by the courts of medicine without registration with the Brazilian Health Regulatory Agency (Anvisa)

Recently, on 22 May 2019, through the judgment of RE 657.718 / MG, the Federal Supreme Court ruled that the

Boehringer partners with The University of Texas MD Anderson Cancer Center on virtual R&D centre

Wednesday, August 14, 2019 Boehringer Ingelheim has collaborated with The University of Texas MD Anderson Cancer Center to create a

CELLINK awarded patent for temperature-controlled printbed technology

Tuesday, August 13, 2019 Bioprinting company CELLINK has been granted a patent from the European Patent Office for a new

MJZanon